Kick it up a notch: Notch signaling and kidney fibrosis

Kidney International Supplements

Volumn 4, Issue 1, 2014, Pages 91-96

  Sweetwyne, Mariya T ^a   Tao, Jianling ^a   Susztak, Katalin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

glomerulosclerosis; Notch; tubulointerstitial fibrosis

Indexed keywords

HELIX LOOP HELIX PROTEIN; JAGGED1; NOTCH RECEPTOR;

ACUTE KIDNEY FAILURE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; GENE DELETION; GLOMERULOSCLEROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BIOPSY; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; NONHUMAN; PATHOGENESIS; PODOCYTE; PROTEIN EXPRESSION; REVIEW; STABLE EXPRESSION; UPREGULATION;

EID: 84908499018     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2014.17     Document Type: Short Survey

References (43)

1. USRDS: the United States renal data system. Am J Kidney Dis 2003; 42(Suppl 5): 1-230.
2. Bonegio R, Susztak K. Notch signaling in diabetic nephropathy. Exp Cell Res 2012; 318: 986-992.
3. Kopan R, Cagan R. Notch on the cutting edge. Trends Genet 1997; 13: 465-467.
4. Ilagan MX, Lim S, Fulbright M et al. Real-time imaging of notch activation with a luciferase complementation-based reporter. Sci Signal 2011; 4: rs7.
5. Vooijs M, Liu Z, Kopan R. Notch: architect, landscaper, and guardian of the intestine. Gastroenterology 2011; 141: 448-459.
6. Sharma S, Sirin Y, Susztak K. The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens 2011; 20: 56-61.
7. Cheng HT, Kim M, Valerius MT et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007; 134: 801-811.
8. Li L, Krantz ID, Deng Y et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16: 243-251.
9. Alagille D, Odievre M, Gautier M et al. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 1975; 86: 63-71.
10. Kamath BM, Podkameni G, Hutchinson AL et al. Renal anomalies in Alagille syndrome: a disease-defining feature. Am J Med Genet A 2012; 158A: 85-89.
11. Kamath BM, Bauer RC, Loomes KM et al. NOTCH2 mutations in Alagille syndrome. J Med Genet 2012; 49: 138-144.
12. Kobayashi T, Kageyama R. Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling. Genes Cells 2010; 15: 689-698.
13. Gupta S, Li S, Abedin MJ et al. Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol Renal Physiol 2010; 298: F209-F215.
14. Kobayashi T, Terada Y, Kuwana H et al. Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008; 73: 1240-1250.
15. Huang R, Zhou Q, Veeraragoo P et al. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the gamma-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail 2011; 33: 207-216.
16. Chen J, Chen JK, Conway EM et al. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol 2013; 24: 2023-2033.
17. Lasagni L, Ballerini L, Angelotti ML et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 2010; 28: 1674-1685.
18. Angelotti ML, Ronconi E, Ballerini L et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012; 30: 1714-1724.
19. Matsusaka T, Xin J, Niwa S et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocytespecific injury. J Am Soc Nephrol 2005; 16: 1013-1023.
20. Murea M, Park JK, Sharma S et al. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 2010; 78: 514-522.
21. Nyhan KC, Faherty N, Murray G et al. Jagged/Notch signalling is required for a subset of TGFbeta1 responses in human kidney epithelial cells. Biochim Biophys Acta 2010; 1803: 1386-1395.
22. Bielesz B, Sirin Y, Si H et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054.
23. Djudjaj S, Chatziantoniou C, Raffetseder U et al. Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol 2012; 228: 286-299.
24. Garber K. Notch emerges as new cancer drug target. J Natl Cancer Inst 2007; 99: 1284-1285.
25. Sharma M, Callen S, Zhang D et al. Activation of Notch signaling pathway in HIV-associated nephropathy. AIDS 2010; 24: 2161-2170.
26. Kato H, Susztak K. Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis. Semin Nephrol 2012; 32: 350-356.
27. Niranjan T, Bielesz B, Gruenwald A et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298.
28. Waters AM, Wu MY, Onay T et al. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008; 19: 1139-1157.
29. Waters AM, Wu MY, Huang YW et al. Notch promotes dynamindependent endocytosis of nephrin. J Am Soc Nephrol 2012; 23: 27-35.
30. Sharma M, Magenheimer LK, Home T et al. Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy. Am J Physiol Renal Physiol 2013; 304: F1127-F1136.
31. Lin CL, Wang FS, Hsu YC et al. Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes 2010; 59: 1915-1925.
32. Rauen T, Grammatikos AP, Hedrich CM et al. cAMP-responsive element modulator alpha (CREMalpha) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE). J Biol Chem 2012; 287: 42525.
33. Pan L, Glenn ST, Jones CA et al. Activation of the rat renin promoter by HOXD10.PBX1b.PREP1, Ets-1, and the intracellular domain of notch. J Biol Chem 2005; 280: 20860-20866.
34. Castellanos Rivera RM, Monteagudo MC, Pentz ES et al. Transcriptional regulator RBP-J regulates the number and plasticity of renin cells. Physiol Genomics 2011; 43: 1021-1028.
35. Koshizaka M, Takemoto M, Sato S et al. An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice. Exp Diabetes Res 2012; 2012: 159874.
36. Lavoz C, Rodrigues-Diez R, Benito-Martin A et al. Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PloS One 2012; 7: e40490.
37. Ozasa Y, Akazawa H, Qin Y et al. Notch activation mediates angiotensin IIinduced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells. Hypertens Res 2013; 36: 859-865.
38. Zavadil J, Cermak L, Soto-Nieves N et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23: 1155-1165.
39. Niranjan T, Murea M, Susztak K. The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol 2009; 111: e73-e79.
40. Cristofaro B, Shi Y, Faria M et al. Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models. Development 2013; 140: 1720-1729.
41. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716.
42. Dai C, Stolz DB, Kiss LP et al. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 2009; 20: 1997-2008.
43. Fabian SL, Penchev RR, St-Jacques B et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol 2012; 180: 1441-1453.